| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/J.GASTRO.2006.11.015 |
| P698 | PubMed publication ID | 17258717 |
| P50 | author | Morten H. Vatn | Q76356809 |
| Bjørn Moum | Q76356899 | ||
| Tomm Bernklev | Q60650914 | ||
| Geir Aamodt | Q73664282 | ||
| P2093 | author name string | Pia Munkholm | |
| Marina Beltrami | |||
| Lene Riis | |||
| Selwyn Odes | |||
| Juan Clofent | |||
| Ole Hoie | |||
| Reinhold W Stockbrügger | |||
| Frank L Wolters | |||
| Epaminondas Tsianos | |||
| European Collaborative Study Group of Inflammatory Bowel Disease | |||
| P433 | issue | 2 | |
| P921 | main subject | ulcerative colitis | Q1477 |
| P304 | page(s) | 507-515 | |
| P577 | publication date | 2006-11-15 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years | |
| P478 | volume | 132 |
| Q35681188 | Alternative specimen extraction techniques after laparoscopic emergency colectomy in inflammatory bowel disease |
| Q33564081 | Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery? |
| Q58693554 | CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis |
| Q53122367 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. |
| Q42360841 | Clinical course and prognosis in ulcerative colitis: results from population-based and observational studies |
| Q43737466 | Clinical practice in the management of ulcerative colitis--an Italian survey |
| Q36144470 | Clinical, serological and genetic predictors of inflammatory bowel disease course |
| Q42738547 | Colectomy and IBD. Does surgery improve survival? |
| Q39920100 | Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis |
| Q36144457 | Crucial steps in the natural history of inflammatory bowel disease. |
| Q35919991 | Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis |
| Q41174352 | Current directions of biologic therapies in inflammatory bowel disease |
| Q40884082 | Do clinical factors help to predict disease course in inflammatory bowel disease? |
| Q89483676 | Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation? |
| Q34007529 | Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis |
| Q39015963 | Extent of disease is a major outcome predictor in patients with ulcerative colitis and pregnancy |
| Q33858229 | First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses |
| Q39085361 | Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis |
| Q89727383 | Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study |
| Q38719570 | How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease |
| Q26774575 | How to predict clinical relapse in inflammatory bowel disease patients |
| Q36919787 | Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity |
| Q26995479 | Impact of medical therapies on inflammatory bowel disease complication rate |
| Q33894191 | Is the disease course predictable in inflammatory bowel diseases? |
| Q46599046 | Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population |
| Q36144464 | Methodology for high-quality studies on course and prognosis of inflammatory bowel disease. |
| Q39381231 | Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. |
| Q37630733 | Natural history and complications of IBD. |
| Q84273563 | Necessity of phenotypic classification of inflammatory bowel disease |
| Q44592949 | Point-counterpoint: Are we overtreating patients with mild ulcerative colitis? |
| Q89667371 | Precision medicine in inflammatory bowel disease: concept, progress and challenges |
| Q55520888 | Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries. |
| Q26751156 | Predictive factors for a severe clinical course in ulcerative colitis: Results from population-based studies |
| Q61445810 | Predictive models of disease burden at diagnosis in persons with adult-onset ulcerative colitis using health administrative data |
| Q33590827 | Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario |
| Q57382914 | Preparation of Colon-Targeted Acetylharpagide Tablets and its Release Properties and |
| Q35670802 | Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study |
| Q47769305 | Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort. |
| Q46014959 | Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. |
| Q41807612 | Recent Research in IBD Epidemiology |
| Q36719865 | Risk factors for complications in patients with ulcerative colitis |
| Q42242578 | Risk factors for proximal disease extension and colectomy in left-sided ulcerative colitis |
| Q43072226 | Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies |
| Q37366145 | Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis |
| Q48585325 | Sexual function and patients' perceptions in inflammatory bowel disease: a case-control survey |
| Q36230705 | Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration |
| Q43096285 | State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. |
| Q36174140 | The Demographic and Clinical Characteristics of Ulcerative Colitis in a Northeast Brazilian Population |
| Q37196042 | The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature |
| Q38254878 | The use of prognostic factors in inflammatory bowel diseases |
| Q39437514 | Total colectomy for ulcerative colitis in children: when are we operating? |
| Q38171924 | Towards personalized care in IBD. |
| Q94340226 | UEG Week 2016 Poster Presentations |
| Q84851901 | Ulcerative colitis |
Search more.